{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:40:03Z","timestamp":1761129603886,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T00:00:00Z","timestamp":1553472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"STAND Clinical Trial"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3911-9","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T13:02:41Z","timestamp":1553518961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug na\u00efve patients in Nairobi, Kenya"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0414-6213","authenticated-orcid":false,"given":"Collins Otieno","family":"Ogari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony Kebira","family":"Nyamache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Nonoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evans","family":"Amukoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,25]]},"reference":[{"issue":"2","key":"3911_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4103\/0974-777X.81691","volume":"3","author":"GK Sandhu","year":"2011","unstructured":"Sandhu GK. Tuberculosis: current situation, challenges and overview of its control programs in India. J Global Infect Dis. 2011;3(2):143.","journal-title":"J Global Infect Dis"},{"issue":"1","key":"3911_CR2","first-page":"21","volume":"20","author":"J Walley","year":"1997","unstructured":"Walley J. DOTS for TB: it\u2019s not easy. Afr Health. 1997;20(1):21\u20132.","journal-title":"Afr Health"},{"issue":"9514","key":"3911_CR3","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S0140-6736(06)68392-X","volume":"367","author":"MC Raviglione","year":"2006","unstructured":"Raviglione MC, Uplekar MW. WHO\u2019s new stop TB strategy. Lancet. 2006;367(9514):952\u20135.","journal-title":"Lancet"},{"issue":"7389","key":"3911_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1136\/bmj.326.7389.574","volume":"326","author":"TR Sterling","year":"2003","unstructured":"Sterling TR, Lehmann HP, Frieden TR. Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis. BMJ. 2003;326(7389):574.","journal-title":"BMJ."},{"key":"3911_CR5","first-page":"10","volume-title":"Kenya tuberculosis prevalence survey 2015\u20132016. Assessing Kenya\u2019s TB burden","author":"Ministry of Health","year":"2017","unstructured":"Ministry of Health. Kenya tuberculosis prevalence survey 2015\u20132016. Assessing Kenya\u2019s TB burden; 2017. p. 10."},{"key":"3911_CR6","unstructured":"World Health Organization. Global tuberculosis report. 2018."},{"key":"3911_CR7","volume-title":"Laboratory manual mycobacteriology","author":"Shortening treatment by Advanced Novel Drugs","year":"2014","unstructured":"Shortening treatment by Advanced Novel Drugs. Laboratory manual mycobacteriology. New York: TB Alliance; 2014."},{"key":"3911_CR8","unstructured":"Hain Life Sciences. \n                    https:\/\/www.hain-lifescience.de\/en\/downloads\/microbiology.html\n                    \n                  . Accessed 2 Jan 2018."},{"key":"3911_CR9","first-page":"41","volume-title":"MGIT procedure manual","author":"SH Siddiqi","year":"2006","unstructured":"Siddiqi SH, R\u00fcsch-Gerdes S. MGIT procedure manual. Geneva: Foundation for innovative new diagnostics; 2006. p. 41\u201351."},{"issue":"11","key":"3911_CR10","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.apjtm.2015.10.014","volume":"8","author":"AS Hoza","year":"2015","unstructured":"Hoza AS, Mfinanga SG, K\u00f6nig B. Anti-TB drug resistance in Tanga, Tanzania: a cross sectional facility-base prevalence among pulmonary TB patients. Asian Pacific J of Trop Med. 2015 Nov 30;8(11):907\u201313.","journal-title":"Asian Pacific J of Trop Med"},{"issue":"6","key":"3911_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jiph.2013.03.003","volume":"6","author":"JP Mathuria","year":"2013","unstructured":"Mathuria JP, Samaria JK, Srivastava GN, Mathuria BL, Ojha SK, Anupurba S. Primary and acquired drug resistance patterns of Mycobacterium tuberculosis isolates in India: a multicenter study. J Infect Public Health. 2013;6(6):456\u201364.","journal-title":"J Infect Public Health"},{"issue":"2","key":"3911_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1128\/CMR.00059-12","volume":"26","author":"A Beceiro","year":"2013","unstructured":"Beceiro A, Tom\u00e1s M, Bou G. Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev. 2013;26(2):185\u2013230.","journal-title":"Clin Microbiol Rev"},{"key":"3911_CR13","first-page":"753492","volume":"2014","author":"B Seyoum","year":"2014","unstructured":"Seyoum B, Demissie M, Worku A, Bekele S, Aseffa A. Prevalence and drug resistance patterns of Mycobacterium tuberculosis among new smear positive pulmonary tuberculosis patients in eastern Ethiopia. Tuberculosis Resea Treat. 2014;2014:753492.","journal-title":"Tuberculosis Resea Treat"},{"issue":"10","key":"3911_CR14","doi-asserted-by":"publisher","first-page":"e0163994","DOI":"10.1371\/journal.pone.0163994","volume":"11","author":"IP Ombura","year":"2016","unstructured":"Ombura IP, Onyango N, Odera S, Mutua F, Nyagol J. Prevalence of drug resistance Mycobacterium tuberculosis among patients seen in coast provincial general hospital, Mombasa, Kenya. PLoS One. 2016;11(10):e0163994.","journal-title":"PLoS One"},{"issue":"11","key":"3911_CR15","first-page":"1320","volume":"13","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis [state of the art series. Drug-resistant tuberculosis. Edited by CY. Chiang. Number 1 in the series]. The I. J Tuberc Lung Dis. 2009;13(11):1320\u201330.","journal-title":"J Tuberc Lung Dis"},{"issue":"1","key":"3911_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1756-0500-1-58","volume":"1","author":"W Urassa","year":"2008","unstructured":"Urassa W, Mugusi F, Villamor E, Msamanga G, Moshiro C, Bosch R, Saathoff E, Fawzi W. Primary antimicrobial resistance among Mycobacterium tuberculosis isolates from HIV seropositive and HIV seronegative patients in Dar Es Salaam Tanzania. BMC resear notes. 2008;1(1):58.","journal-title":"BMC resear notes"},{"issue":"5","key":"3911_CR17","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1128\/JCM.40.5.1636-1643.2002","volume":"40","author":"J Bruchfeld","year":"2002","unstructured":"Bruchfeld J, Aderaye G, Palme IB, Bjorvatn B, Ghebremichael S, Hoffner S, Lindquist L. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol. 2002;40(5):1636\u201343.","journal-title":"J Clin Microbiol"},{"key":"3911_CR18","doi-asserted-by":"crossref","unstructured":"Kidenya BR, Mshana SE, Fitzgerald DW, Ocheretina O. Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-Western Tanzania. Tuberculosis. 109:97\u2013101.","DOI":"10.1016\/j.tube.2018.02.004"},{"issue":"6","key":"3911_CR19","first-page":"428","volume":"7","author":"M Moreno Gomez","year":"2005","unstructured":"Moreno Gomez M, Miron Canelo JA, Alonso Sardon M, Saenz Gonzalez MC. Therapeutic compliance and treatment results of patients with tuberculosis. Atencion Farmaceutica. 2005;7(6):428.","journal-title":"Atencion Farmaceutica"},{"issue":"3","key":"3911_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1440-1843.2010.01738.x","volume":"15","author":"CY Chiang","year":"2010","unstructured":"Chiang CY, Centis R, Migliori GB. Drug-resistant tuberculosis: past, present, future. J Respirology. 2010;15(3):413\u201332.","journal-title":"J Respirology"},{"key":"3911_CR21","unstructured":"Sharma SK, Kaushik G, Jha B, George N, Arora SK, Gupta D, Singh U, Hanif M, Vashisht RP. Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. Indian J Med Research. 133(3):308."},{"issue":"1","key":"3911_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tube.2013.08.009","volume":"94","author":"BR Kidenya","year":"2014","unstructured":"Kidenya BR, Webster LE, Behan S, Kabangila R, Peck RN, Mshana SE, Ocheretina O, Fitzgerald DW. Epidemiology and genetic diversity of multidrug-resistant tuberculosis in East Africa. Tuberculosis. 2014;94(1):1\u20137.","journal-title":"Tuberculosis."},{"issue":"5","key":"3911_CR23","first-page":"494","volume":"9","author":"EA Nunes","year":"2005","unstructured":"Nunes EA, De Capitani EM, Coelho E, Joaquim OA, Figueiredo IR, Cossa AM, Panunto AC, Carvalho-Ramos M. Patterns of anti-tuberculosis drug resistance among HIV-infected patients in Maputo, Mozambique, 2002\u20132003. The I. J Tuberc Lung Dis. 2005;9(5):494\u2013500.","journal-title":"J Tuberc Lung Dis."},{"issue":"2","key":"3911_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.5588\/ijtld.13.0369","volume":"18","author":"E Sanchez-Padilla","year":"2014","unstructured":"Sanchez-Padilla E, Marquer C, Kalon S, Qayyum S, Hayrapetyan A, Varaine F, Bastard M, Bonnet M. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study. Int J Tuberc Lung Dis. 2014;18(2):160\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3911_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijid.2016.10.016","volume":"56","author":"D Cazabon","year":"2017","unstructured":"Cazabon D, Alsdurf H, Satyanarayana S, Nathavitharana R, Subbaraman R, Daftary A, Pai M. Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade. Int J Infect Dis. 2017;56:111\u20136.","journal-title":"Int J Infect Dis"},{"issue":"8","key":"3911_CR26","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1128\/AAC.00102-13","volume":"57","author":"Y Hu","year":"2013","unstructured":"Hu Y, Hoffner S, Wu L, Zhao Q, Jiang W, Xu B. Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in rural China. Antimicrob Agents Chemother. 2013;57(8):3857\u201363.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3911_CR27","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1086\/590009","volume":"47","author":"R Banerjee","year":"2008","unstructured":"Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J. Extensively drug-resistant tuberculosis in California, 1993\u20132006. Clin Infect Dis. 2008;47(4):450\u20137.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3911_CR28","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1128\/AAC.48.2.596-601.2004","volume":"48","author":"AF Cheng","year":"2004","unstructured":"Cheng AF, Yew WW, Chan EW, Chin ML, Hui MM, Chan RC. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother. 2004;48(2):596\u2013601.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"3911_CR29","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.7150\/ijms.6806","volume":"10","author":"F Biadglegne","year":"2013","unstructured":"Biadglegne F, Tessema B, Rodloff AC, Sack U. Magnitude of gene mutations conferring drug resistance in mycobacterium tuberculosis isolates from lymph node aspirates in Ethiopia. Int J Med Sci. 2013;10(11):1589.","journal-title":"Int J Med Sci"},{"issue":"8","key":"3911_CR30","doi-asserted-by":"publisher","first-page":"e70763","DOI":"10.1371\/journal.pone.0070763","volume":"8","author":"D Lukoye","year":"2013","unstructured":"Lukoye D, Adatu F, Musisi K, Kasule GW, Were W, Odeke R, Kalamya JN, Awor A, Date A, Joloba ML. Anti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national survey. PLoS One. 2013;8(8):e70763.","journal-title":"PLoS One"},{"issue":"2","key":"3911_CR31","doi-asserted-by":"publisher","first-page":"e1000002","DOI":"10.1371\/journal.pmed.1000002","volume":"6","author":"A Sandgren","year":"2009","unstructured":"Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, Murray MB. Tuberculosis drug resistance mutation database. PLoS Med. 2009;6(2):e1000002.","journal-title":"PLoS Med"},{"issue":"10","key":"3911_CR32","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/tmi.12359","volume":"19","author":"D Zhang","year":"2014","unstructured":"Zhang D, Liu B, Wang Y, Pang Y. Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China. Trop Med Int Health. 2014;19(10):1259\u201366.","journal-title":"Trop Med Int Health"},{"issue":"8","key":"3911_CR33","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1128\/AAC.49.8.3192-3197.2005","volume":"49","author":"CE Maus","year":"2005","unstructured":"Maus CE, Plikaytis BB, Shinnick TM. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2005;49(8):3192\u20137.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3911-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3911-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3911-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:08:59Z","timestamp":1585008539000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3911-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,25]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3911"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3911-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2019,3,25]]},"assertion":[{"value":"3 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"279"}}